Control of glycolysis in pathologic cardiac hypertrophy

被引：0
|
作者：
Parsons, H [1 ]
Wambolt, R [1 ]
Saeedi, R [1 ]
Allard, M [1 ]
机构：
[1] iCapture Ctr, Vancouver, BC V6Z 1Y6, Canada
来源：
FASEB JOURNAL | 2006年 / 20卷 / 04期
关键词：
D O I：
暂无
中图分类号：
Q5 [生物化学]; Q7 [分子生物学];
学科分类号：
071010 ; 081704 ;
摘要：
引用
收藏
页码：A739 / A739
页数：1
相关论文
共 50 条
  • [21] Modulation of the calcineurin/NFAT pathway by myoglobin inhibits pathologic cardiac hypertrophy
    Chirumamilla, R.
    Singh, S.
    Nguyen, T.
    Gerard, R. D.
    Yan, Z.
    Hill, J. A.
    Mammen, P. P.
    JOURNAL OF INVESTIGATIVE MEDICINE, 2008, 56 (03) : 652 - 652
  • [22] Protein Kinase GIα Functions in the Cardiac Myocyte as a Tonic Inhibitor of Pathologic Cardiac Hypertrophy In Vivo
    Blanton, Robert M.
    Mendoza, James P.
    Aronovitz, Mark
    Kass, David A.
    Mendelsohn, Michael E.
    Karas, Richard H.
    CIRCULATION RESEARCH, 2012, 111 (04)
  • [23] PHYSIOLOGIC OR PATHOLOGIC HYPERTROPHY
    KRAYENBUEHL, HP
    HESS, OM
    SCHNEIDER, J
    TURINA, M
    EUROPEAN HEART JOURNAL, 1983, 4 : 29 - 34
  • [24] CARDIAC HYPERTROPHY AND INSUFFICIENCY OF UNKNOWN ETIOLOGY - A CLINICAL AND PATHOLOGIC STUDY OF 10 CASES
    ELSTER, SK
    HORN, H
    TUCHMAN, LR
    AMERICAN JOURNAL OF MEDICINE, 1955, 18 (06): : 900 - 922
  • [25] Domneg Fos (AFOS) improves cardiac myocyte function in pathologic hypertrophy in vitro
    Long, Carlin S.
    Jeong, Mark Y.
    JOURNAL OF MOLECULAR AND CELLULAR CARDIOLOGY, 2007, 42 : S133 - S133
  • [26] Cardiac hypertrophy of unknown cause - A study of the clinical and pathologic features in ten adults
    Levy, RL
    Von Glahn, WC
    AMERICAN HEART JOURNAL, 1944, 28 : 714 - 741
  • [27] NDRG1 Regulates Iron Metabolism and Inhibits Pathologic Cardiac Hypertrophy
    Yuan, Jiali
    Yin, Chengye
    Peng, Hong
    Fang, Guojian
    Mo, Binfeng
    Qin, Xiji
    Chen, Yuhan
    Wang, Zhengshuai
    Yu, Yichi
    Wang, Yuepeng
    Wang, Qunshan
    CANADIAN JOURNAL OF CARDIOLOGY, 2025, 41 (02) : 224 - 240
  • [28] YAP mediates compensatory cardiac hypertrophy through aerobic glycolysis in response to pressure overload
    Kashihara, Toshihide
    Mukai, Risa
    Oka, Shin-ichi
    Zhai, Peiyong
    Nakada, Yasuki
    Yang, Zhi
    Mizushima, Wataru
    Nakahara, Tsutomu
    Warren, Junco S.
    Abdellatif, Maha
    Sadoshima, Junichi
    JOURNAL OF CLINICAL INVESTIGATION, 2022, 132 (06):
  • [29] The enhancing effects of selenomethionine on harmine in attenuating pathological cardiac hypertrophy via glycolysis metabolism
    Chen, Qi
    Wang, Wen-Yan
    Xu, Qing-Yang
    Dai, Yan-Fa
    Zhu, Xing-Yu
    Chen, Zhao-Yang
    Sun, Ning
    Leung, Chung-Hang
    Gao, Fei
    Wu, Ke-Jia
    JOURNAL OF CELLULAR AND MOLECULAR MEDICINE, 2024, 28 (19)
  • [30] Control of Cardiac Hypertrophy and Fibrosis by the Notch Pathway
    Nemir, Mohamed
    Metrich, Melanie
    Plaisance, Isabelle
    Lepore, Mario
    Berthonneche, Corinne
    Sarre, Alexandre
    Radtke, Freddy
    Pedrazzini, Thierry
    CIRCULATION, 2011, 124 (21)
12345